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Abstract
Background: Hearing loss is a problem with higher incidence in South Asia, Asia Pacific and sub-Saharan
Africa. In these countries there is also associated history of anemia and malaria.
Objective: This study aims to identify a putative role of Beta globin mutation - sickle cell trait and HL in São Tomé
and Príncipe population.
Methods: A retrospective case-control study of a convenience sample was collected during Otolaryngologist
Humanitarian Missions in São Tomé and Príncipe. Control group includes individuals with normal hearing in both
ears, and the case group has participants presenting bilateral or unilateral HL. It was evaluated the potential risk
factors and sickle cell trait with HL, as well self-report of malaria infection, consanguinity, familial history of HL. The
HbS gene point mutation (Glu6Val) was determined by PCR-RFLP.
Results: Our results showed a statistical significance between HL - oral language and self-report of HL. Taken
altogether, our data did not reveal association between sickle cell trait and HL. However, a statistical association
between HL and self-report of malaria was found.
Conclusion: No association between sickle cell trait and the high prevalence of HL was found. Self-report of
Malaria was found as a risk factor for the development of HL in São Tomé and Príncipe population. The multifactorial
profile of HL shall not exclude the relevance of other etiologic factors than Malaria to justify the high prevalence of
HL in São Tomé and Príncipe and further investigation must be applied.
Keywords Hearing loss; Sensorineural hearing loss; São tomé and
príncipe; Sickle cell trait; Sickle cell disease; Malaria;
Hemoglobinopathies
Introduction
More than 360 million people in the World have disabling hearing
loss (HL). According to new World Health Organization (WHO)
Global Estimates on prevalence of the HL [1,2], there is a higher
incidence in South Asia, Asia Pacific and sub-Saharan Africa [1-3].
Sub-Saharan Africa holds 10% of the world’s population and two thirds
of the world’s least developed nations.
More than 1.2 million of the children living in sub-Saharan Africa
aged 5 to 14 years old have moderate to severe bilateral HL [3]. The
consequences of hearing problems are well known. HL in children can
result in developmental delays and lead to significant inability to
engage in oral/aural communication.
Anemia has been proposed as an etiologic factor in sensorineural
deafness for many years, but there is little supporting evidence [4]. In
these African countries there is a high prevalence of anemia and this
could be associated with infections, hemoglobinopathies or stunting
[5].
Several gene mutations and polymorphisms in the human hosts
confer survival advantage and have increased in frequency through
natural selection over generations. These include hemoglobinopathies
like Sickle Cell Disease (SCD), thalassemias and glucose-6-phosphate
dehydrogenase (G6PD) deficiency. Sickle Cell Disease (SCD) refers to
a group of symptomatic disorders associated with a specific mutation
on the Beta globin (HBB) gene [6]. Sickle hemoglobin (HbS), a
structural variant of normal adult hemoglobin, results in the
substitution of glutamic acid with valine in the sixth position of β-
chain of the hemoglobin (β6Glu-Val) [7]. HbS is the most common
pathological hemoglobin variant worldwide [7].
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Several studies have suggested that HbS has an effect of protection
against Plasmodium falciparum, the etiologic agent of malaria [6],
showing that heterozygous people carrying the sickle-cell trait (HbAS)
are protected against severe malaria (prevalence of HbAS, in some
populations, is above 90%) [6,8].
This mechanism act as natural selection and is co-responsible for
the high prevalence of HbS in malaria endemic regions as a result of
natural selection over generations [9].
The red cells of individuals with the mutant homozygous gene
(HbSS) become sickle shaped in low oxygen tension pressure with
reduced oxygen-carrying capacity. The basal turn of the cochlea is
particularly sensitive to anoxia, due to the high oxygen consumption
rate of the stria vascularis and poor capacity for anaerobic metabolism.
In this cases, SNHL start with the loss on the higher frequencies, then
the lower frequencies, resulting from the damage at the apical region
(low frequencies) and finally loss of the function throughout the entire
cochlea [8].
SNHL is one of the several complications of this disease and has
been found to occur in 8% of SCD children in Nigeria, 12% in USA,
22% in Jamaica, 36.5% in Kenya and 60% in Ghana [3,8].
In some studies, HbAS in malaria exposure could be also a cause of
SNHL [10].
São Tomé and Príncipe it’s an archipelago in western equatorial
Africa, near Gabon, Equatorial Guinea, Camaroon and Nigeria, with
Portuguese as official language [11]. São Tomé and Príncipe was
discovered by Portuguese explorers in 1470. The resident population is
about 187,000 inhabitants who have a low average age distribution
(17-18 years) with low socioeconomic conditions and poor sanitary
conditions, as well as a public health infection problem–malaria [12–
14].
Since 2011 an otolaryngologist group formed by 2 doctors, 2 nurses
and 1 audiologist began humanitarian missions in São Tomé and
Príncipe (Project “Health for all”–Instituto Marquês de Valle Flor
(IMVF)). Apparently according their clinical registries, this was the
first hearing evaluation performed in these islands. Upon the first
mission, a high prevalence of SNHL in the population was identified
and it was observed upon subsequent missions.
As far as we know this is the first study developed in São Tomé and
Príncipe population to evaluate the causes inherent to the high
incidence of HL in this population. Such way, this study proposes to
answer the question: will it be possible to establish an association
between the sickle cell trait (HbAS) and the high incidence of SNHL in
São Tomé and Príncipe?
Materials and Methods
Subjects
We present a case-control study, with a convenience sample where
the control group include individuals with normal hearing in both
ears, and patients with unilateral or bilateral HL compose the case
group. The project was submitted and approved by the Medical Ethics
Committee of São Tomé and Príncipe and Ethics Research Committee
NMS|FCM-UNL.
A total of 316 individuals (136 HL patients and 180 controls with
bilateral normal hearing), ranging from 2 to 35 years old, agreed to
participate in this study. The limitation to 35 years was chosen to avoid
action of other risk factors of HL, like acoustic trauma, age and the
effect of other diseases. We organized into two age groups based on
WHO: 1) below 14 years old (2–14 years) as children group and 2)
above 15 years old (15–35 years) as adults group. The patients were
recruited during consultation provided by the humanitarian missions
in São Tomé and Príncipe over a period from February 2012 to May
2014. The controls (normal hearing bilateral) were recruited at
consultation at health services, primary schools from São Tomé and
local hotel.
All patients signed an informed consent and answered a clinical
questionnaire recording risk factors and clinical history. An
otolaryngologist observed all. The risk factors included were family
history of HL, consanguinity, self-report of malaria infection, pre-natal
and perinatal history and history of infections.
All 316 individuals were evaluated regarding their hearing status
with Pure Tone Audiogram (PTA) or Auditory Brainstem Response
(ABR) depending on collaboration to participate on the audiometric
exams.
Audiometric exams were carried out by an audiologist without an
audiometric cabin, with earphones-TDH39, in a closed room, with a
level of noise measured by iPhone using SchabelDoesIT GbR, Munich,
Germany (version 1.0.0), considered acceptable (ANSI S3.1-1999)
(R2013). The equipment used was the Madsen Midimate 622 and
Vivosonic Integrity V500 audiometer (auditory brainstem response),
calibrated according to calibration ISO389 1975/Oslo
Recommendation. The IntegrityTM V500 system used to collect
auditory brainstem is a modular equipment comprised by 4 main
components: the computer, the VivoLink (SN: VL0026), the
Amplitrode (SN: AJ0270) and the earphones. The earphones used were
the ER-3A (ER-3A Left SN:63762 e ER-3A Right SN: 63763) and were
calibrated according to ANSI S3.6-1996 and the stimulus used was the
CLICK, calibrated in dB equivalent to the sound pressure level
(dBpeSPL) according to the procedure IEC 60645-3 for the calibration
of short duration stimulus.
Electrophysiological thresholds were translated into the audiometric
thresholds for frequencies 2000 Hz and 4000 Hz. No correction factor
was applied as is advocated in studies conducted by Jerger and
Mauldin [15]; Gorga et al. [16]; van der Drift et al. [17]; Gorga et al.
[18] in which establish a strong correlation between the
electrophysiological thresholds with the "click" and the audiometric
thresholds at 2000 and 4000 Hz.
The hearing loss of each patient was determined based on the better
ear and following the WHO classification [19].
Patients with less than 2 years and more than 35 years of age,
conductive hearing loss, syndromic hearing loss, obvious
environmental causes such as meningitis, cerebral malaria, intra-
uterine or neonatal complications, ototoxicity, severe head trauma or
developmental delay were excluded.
DNA extraction
Blood samples of all patients and controls were collected into
Guthrie cards. Genomic DNA was obtained from each sample using a
commercially available kit (QIAamp® DNA micro kit, Qiagen)
according to the manufacturer’s instructions. All DNA samples were
stored at –20°C.
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SNP screening
The HbS gene point mutation (Glu6Val) was determined by PCR-
RFLP. The primers and PCR conditions for the mutation site of this
gene is shown in Table 1. For all of them the nucleotide mutated
resulted in either gain or loss of restriction site, which therefore
allowed the wild-type (HbAA) and variant alleles to be discriminated
by RFLP after appropriate restriction enzyme digestion.
PCR was carried out with 50 ng of DNA in 50 ml reaction volume,
containing 1.3x ImmoBuffer, 1.5 mM MgCl2, 0.6 mM dNTP, 1.0 mM
of each primer, and 0.75 U of Immolase (Bioline). The amplification
started with an initial denaturation step at 95°C for 7 min, cycling
parameters were 35 cycles of 95°C for 30 s, specific annealing
temperature (60°C) for 30 s, 72°C for 30 s and a final extension at 72°C
for 10 min. After amplification, 10 ml of each PCR products were
digested with appropriate restriction enzymes (DdeI) for 3 h at 37°C
followed by an inactivation step at 65°C for 20 min and
electrophoresed in 2% agarose gel with ethidium bromide (0.5 mg/ml)
for visualization under ultraviolet light. The expected products for each
genotype of the tested gene are shown in Table 1. All the genotype
determinations were carried out twice in independent experiments and
inconclusive samples were reanalyzed.
Gene Primers PCR fragment
Patterns after restriction enzyme
digestion
HbAS codon 6 (rs334) Rv 5’- AGG GTG GGA AAA TAG ACC AA -3’ 395 bp HbAA: 202, 180, 13 bp
 FW 5’- CGG CTG TCA TCA CTT AGA CCT -3’  HbAS: 382, 202,180,13 bp
   HbSS: 382, 13 bp
Table 1: PCR-RFLP conditions for identification of HbAS (rs334) polymorphism.
Statistical Analysis
The Hardy-Weinberg equilibrium of HbS was assessed by Qui-
square test, calculated by HW calculator™ - Michael H Court
(2005-2008).
Description of the sample was made with descriptive statistics,
considering frequency analysis, means and standard deviation (SD).
To study the association between HL and each of the following
parameters as district origin, oral language, perception of HL, sex and
history of malaria infection, have been used the Qui-squared test.
The association between HbS genotype and the degree of HL of each
ear and was analysed with Qui-square test by Monte Carlo Simulation.
To identify risk factors of HL we adopted a Binary Logistic
Regression, where HL is a response variable and independent variables
were HbS, age groups and self-report of Malaria infection.
All analyses were performed using the IBM, SPSS 20 version.
Results
We evaluated 316 subjects (Table 2) of whom 146 (45.6%) were men
and 172 (54.4%) were women, with an age mean of 17.4 ± 9.74 years
and a median of 15 years.
 
Control-
180
Case-
136
Case
Unil HL
Case
Bil HL
p-
Value
Age range  0.361
[2-14]
82
(45.6%)
69
(50.7%)
15
(34.1%)
54
(58.7%)  
[15-35]
98
(54.4%)
67
(49.3%)
29
(65.9%)
38
(41.3%)  
Mean Age SD
17.8±9.7
7
16.9±9.7
3
20.1±9.2
9
15.4±9.6
1  
Sex  0.256
Male:
87
(48.3%)
57
(41.9%)
17
(38.6%)
40
(43.5%)  
Female:
93
(51.7%)
79
(58.1%)
27
(61.4%)
52
(56.5%)  
Oral Language  0.0001
No: 4 (2.2%)
33
(24.3%) 1 (2.3%)
32
(34.8%)  
Yes:
170
(94.5%)
85
(62.5%)
42
(95.4%)
43
(46.7%)  
Indefined: 6 (3.3%)
18
(13.2%) 1 (2.3%)
17
(18.4%)  
Family
History
Hearing Loss  0.278
No:
140
(77.8%)
115
(84.6%)
40
(90.9%)
75
(81.5%)  
Yes:
34
(18.9%)
20
(14.7%) 4 (9.1%)
16
(17.4%)  
Missing: 6 (3.3%) 1 (0.7%)  1 (1.1%)  
Consanguinity  0.443
No:
171
(95%)
127
(93.4%)
43
(97.7%)
84
(91.3%)  
Yes: 3 (1,7%) 4 (2.9%) 1 (2.3%) 3 (3.3%)  
Missing: 6 (3.3%) 5 (3.7%)  5 (5.4%)  
Malaria  0.07
No: 72 (40%)
41
(30.1%) 11 (25%)
30
(32.6%)  
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Yes:
103
(57.2%)
91
(66.9%) 33 (75%)
58
(63.1%)  
Missing 5 (2.8%) 4 (3%)  4 (4.3%)  
Hearing Loss   
Normal:
180
(100%)
44
(32.3%)
44
(100%)   
Mild:  
16
(11.8%)  
16
(17.4%)  
Moderate:  19 (14%)  
19
(20.7%)  
Severe:  
17
(12.5%)  
17
(18.5%)  
Profound:  
40
(29.4%)  
40
(43.5%)  
Right Ear   
Normal:
180
(100%) 19 (14%)
19
(43.2%)   
Mild:  
26
(19.1%)
13
(29.5%)
13
(14.1%)  
Moderate:  
17
(12.5%) 3 (6.8%)
14
(15.2%)  
Severe:  
17
(12.5%) 2 (4.5%)
15
(16.3%)  
Profound:  
57
(41.9%) 7 (15.9%)
50
(54.3%)  
Left Ear   
Normal:
180
(100%)
25
(18.4%)
25
(56.8%)   
Mild:  
18
(13.2%) 8 (18.2%)
10
(10.9%)  
Moderate:  19 (14%) 1 (2.3%)
18
(19.6%)  
Severe:  
16
(11.8%) 2 (4.5%)
14
(15.2%)  
Profound:  
58
(42.6%) 8 (18.2%)
50
(54.3%)  
Hb  0.743
HbAA:
142
(78.9%)
112
(82.3%)
35
(79.5%)
77
(83.7%)  
HbAS:
35
(19.4%)
22
(16.2%) 9 (20.5%)
13
(14.1%)  
HbSS: 3 (1.7%) 2 (1.5%) 0 2 (2.2%)  
SD – Standard Deviation; HbAA - Wild Type; HbAS - Trait; HbSS - Homozygotic
Table 2: General characteristics for convenience sample of São Tomé
and Príncipe population.
Both groups (case-control) are homogeneous to gender (p=0.256)
and age groups (p=0.361).
According to our results, HL is not associated with the district of
origin (p=0.058) of each individual.
Figure 1: Case/control group distribution by HL grade.
Among the 316 subjects, we found 180 (57.0%) individuals with
bilateral normal hearing, 44 (13.9%) unilateral HL (UHL) and 92
(29.1%) with bilateral HL (Figure 1). The individuals with UHL and
bilateral HL were included in the case group.
Figure 2: The Hardy-Weinberg Principle for HbS genotype was
confirmed (p>0.05).
The Hardy-Weinberg Principle for HbS genotype was confirmed
based on the distribution of HbS genotype in control and case group
(Figure 2).
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When we calculate the media of the tone threshold, we found the
left ear (40.02 dB) slight the same than the right (39.85 dB). The
audiometric curve in the global sample has a horizontal shape, around
mild HL.
The self-reported HL was confirmed by the audiometric evaluation,
showing a positive association (p<0.0001) between both parameters.
The tendency for self-reported HL was confirmed by the exams
(ϕ=0.553; p<0.0001).
Considering oral language for communication, this was absent in 33
(24.3%) of the individuals from case group and in 4 (2.2%) of the
control groups these showing a negative association (ϕ=-0.379;
p<0.0001) between oral language and HL (p<0.0001). There was a
tendency to have oral language in the control group.
A familial history of HL was found to be more prevalent in the
control group than in the case group, respectively with 34 controls
(18.9%) and 20 patients (14.7%). In the case group, 16 (80%) had
bilateral HL and 4 (20%) unilateral HL.
From our sample 3 individuals (1.7%) in the control group and 4
patients (2.9%) in case group confirmed the existence of consanguinity
in their families. Thus, no association between HL and consanguinity
was performed.
In São Tomé and Principe we did not found any registry about
history of malaria infection. At same time, we found that malaria
infection is a public health problem and all individuals enrolled
recognize malaria infection and can answer about their clinical history
regarding this endemic infection. Self-report of malaria infection was
more prevalent in the case group with 91 patients reporting a history of
malaria (66.9%), being reported by 103 individuals (57.2%) of the
control group.
The genotype distribution in our population was shown in Table 2.
Concerning our results the HbAS showed no significant predisposition
to HL (Table 3).
 Cases n (%) Controls n (%) P-value Crude OR (95% CI) P-value Adjusted OR (95% CI)
Age group   0.362  0.07  
[2-14] 69 (45.7%) 82 (54.3%)  Reference  Reference
[15-35] 98 (59.4%) 98 (59.4%)  0.812 [0.520-1.269]  0.633 [0.386-1.038]
Malaria infection   0.071  0.021  
No: 41 (30.1%) 72 (40%)  Reference  Reference
Yes: 91 (66.9%) 103 (57.2%)  1.552 [0.964-2.497]  1.840 [1.097-3.085]
HbS   0.744  0.839  
(HbAA) 112 (82.3%) 142 (78.9%)  Reference  Reference
(HbAS) 22 (16.2%) 35 (19.4%) 0.449 0.797 [0.443-1.435] 0.573 0.842 [0.463-1.530]
(HbSS) 2 (1.5%) 3 (1.7%) 0.855 0.845 [0.139-5.145] 0.832 0.821 [0.133-5.063]
Table 3: Binary logistic regression between HbS and HL without and with risk factors (age group and history of malaria infection), HL: Normal
hearing–0–Reference Category is a response variable; independent variables: HbS (0–HbAA wild type, 1- HbAS trait, 2–HbSS homozygotic), age
groups (0–[2-14] years, 1–[15-35] years) and history of Malaria infection (0–no, 1–yes).
By applying the model of binary logistic regression the self-report of
malaria was identified as a risk factor for HL (Table 3). The history of
malaria infection almost doubled the risk of HL (OR=1.840; CI 95%
[1.097-3.085]). We also found that, even not statistically significant, the
oldest age group presented a decreased risk of HL in 36.7%.
For sickle cell trait we did not verify a significant predisposition to
develop HL (OR=0.842; CI95% [0.463-1.530]) as sickle cell disease
(OR=0.821; CI95% [0.133-5.063]).
Discussion
The results of this study revealed a prevalence of bilateral SNHL in
92 (29.1%) individuals and unilateral SNHL in 44 (13.9%) of subjects
from our convenience sample. The unilateral and bilateral SNHL,
accounting for 43% of the total sample, were included in the case study
group since the unilateral SNHL also contribute to worse language
acquisition and decreased school performance [20].
The horizontal audiologic curve in tonal audiogram was not specific
or characteristic to a specific risk factor, meaning that inumerous
causes may be responsible for SNHL in São Tomé and Príncipe and not
one in particular.
Analysing the risk factors, the history family of HL and
consanguinity were excluded from the analysis because they have a
small number of cases. They haven’t significant association in contrast
to what we are expecting, since has been reported the relevance of
these factors in HL [21, 22].
The individuals included in this study rarely reported to have
consanguineous parents, even knowing that São Tomé and Príncipe are
small islands, with high probability of consanguinity.
São Tomé and Príncipe is a population of Sub-Saharan Africa in
which several haemoglobinopathies have been identified, including
HbSS as the most prevalent [7,23]. It would be expected to obtain an
increased prevalence of HbS homozygous (HbSS) and increased HbAS
[4,8,10,24] in the São Tomé and Príncipe population. However in our
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results, HbSS genotype were found only in 16% and 18% for HbAS of
the sample.
The HbAS has been reported in many studies as a factor of
protection from malaria, reducing its severity [6]. The mechanism that
contribute for this protection is the accelerated sickling of parasite-
infected HbAS erythrocytes, low growth rates and parasite invasion in
HbAS erythrocytes (in low oxygen conditions) and increased
phagocytosis of infected HbAS erythrocytes [6]. Recently, had been
show that intra-erythrocytic parasite growth is greatly inhibited by
HbS polymerization when oxygen levels drop below 5% and, higher
parasite-infected sickle erythrocyte phagocytosis by host immune cells
has been observed when compared to infected normal erythrocytes
[6]. Moreover, HbS erythrocytes infected by P. falciparum lower the
surface expression of PfEMP-1, which results in a reduction of
cytoadherence and thus protection against severe malaria [6]. This
haemoglobin alteration otherwise may lead to thromboembolic events
which sought being the source of SNHL [10].
The study model adopted did not confirm this assumption that the
HbAS can promote SNHL. In our study we found a significant
association between SNHL and a self-report of malaria. Although the
patient provides the clinical malaria episode information, we
considered their report valid. We must also consider that in the São
Tomé Príncipe population exists a strong public awareness of Malaria
infection as public health problem and standard procedures and
guidelines for infection evaluation are followed, including the
collection of thick blood film Plasmodium sp. in the presence of fever
and illness.
Our results are supported by others, suggesting also that mild
clinical malaria may also be associated with SNHL [25,26].
The malaria infection may trigger the onset of SNHL by
pathophysiological processes, thromboembolism and release of
inflammatory mediators [26,27]. On the other hand, malaria treatment
adopted may be ototoxic. Some studies report reversibility of
ototoxicity of some antimalarial [28–32]. In the specific case of
children it does not apply [33] especially when is not performed a drug
weight adjustment, and children ingest high doses of antimalarial
therapy which may induce irreversible ototoxicity [32,33]. Eventually
the higher association of the youngest patients of the case group with
HL could be supported by the report of children malaria infection in
this country during last 14 years [34,35].
The epidemiological profile of Malaria in São Tomé and Príncipe
reveals a significant decrease of malaria admissions and deaths over
2006-2007 [34]. Since then, the children were most affected,
representing a high proportion relatively to all patients. In 2003 they
started some measures to control the disease witch include indoor
residual spraying (IRS). In 2004 initiated the intermittent preventive
treatment (IPT) with and sulfadoxine and pyrimethamine and changed
the antimalarial policy with association of artesunate (AS) and
amodiaquine (AQ), as first line treatment, in 2005 implemented the
use of insecticide-treated nets (ITN) [34].
Our results support the hypothesis that the sickle cell trait (HbAS)
acts as a protective role against malaria and SNHL in São Tomé and
Príncipe.
Moreover, although São Tomé and Príncipe region is also affected by
other HBB mutations, their prevalence is not relevant [23], justifying
no screening for them in our study. There are others haemoglobin
diseases, like deficiency of glucose-6-phosphate dehydrogenase, which
ototoxicity is well known when combined with primaquine
antimalarial therapy [36,37].
Conclusion
No association between sickle cell trait (HbAS) and the high
prevalence of HL was found. However, our study suggests that in this
sample, HbAS is preventing HL because is protecting against malaria.
Malaria was found as a risk factor for the development of HL in São
Tomé and Príncipe population. The multifactorial profile of HL and
the horizontal audiologic curve, highly suggests the relevance of other
etiologic factors than Malaria to justify the high prevalence of HL in
São Tomé and Príncipe and further investigation must be applied.
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